| Line item | 2025-03-31 FY | 2024-03-31 FY | 2023-03-31 FY | 2022-03-31 FY | 2021-03-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | $276.32K | – | – |
| Cost of Revenue | – | – | $276.32K | $710.51K | $1.23M |
| Gross Profit | – | – | -$40.45K | $210.79K | $16.54K |
| Operating Expenses | $1.53M | $2.12M | $323.13K | $553.92K | $287.19K |
| R&D | – | – | – | – | – |
| SG&A | $762.48K | $1.42M | $248.95K | $449.36K | $205.30K |
| Operating Income | -$1.14M | -$2.13M | $348.93K | $126.52K | $302.29K |
| Interest Expense | – | – | – | – | – |
| Tax Expense | – | – | – | – | – |
| Net Income | -$1.14M | -$2.13M | -$348.93K | -$126.52K | -$302.29K |
| EPS (basic) | -0.0100 | -0.0200 | 0.0000 | 0.0000 | 0.0000 |
| EPS (diluted) | – | – | – | – | – |
| Shares (diluted) | – | – | – | – | – |